Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
Keck Medicine of USC is conducting a clinical trial that explores using steam as a potential alternative to surgery or ...
Sudha Sundar, Professor of Gynae Cancer and NHS Consultant Gynae Cancer Surgeon said that as women go through menopause, ...
The expert said that these common symptoms should make you see a GP and if caught early, the better the outcome ...